Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.
Here are three things to know:
1. The patent covers Kuros' technology for the production of osteoinductive calcium phosphates, which feature a surface topography designed to instruct stem cells and osteoprogenitor cells to differentiate into bone-forming cells.
2. The company is forming a patent portfolio and submitting patent applications to protects its proprietary MagnetOs product family.
3. MagnetOs is a bone graft substitute designed to fill bony voids or gaps to promote the bone formation at the implantation site.